Transformation Capital
VC Fund
Boston, United States
Transformation Capital is a VC fund in Boston focused on Health Care and Medical. Transformation Capital is the successor management company to Leerink Transformation Partners LLC (“LTP”).11 LTP was founded in 2016 by Todd Cozzens and Jared Kesselheim, MD together with SVB Leerink Capital LLC (formerly Leerink Capital Partners LLC) (“Leerink Capital”), an affiliate of SVB Leerink LLC (“Leerink”), a leading healthcare investment bank. Leerink Capital provided seed capital to Fund I (approximately 3% of capital commitments) and operational support. In January 2019, SVB Financial Group (“SVB”), the holding company of Silicon Valley Bank, a U.S.-based high-tech commercial bank, acquired the Leerink businesses including Leerink Capital. Todd Cozzens, Jared Kesselheim, MD, and SVB expect to agree to a mutually beneficial ongoing relationship in which Transformation Capital (as an independent management company owned by Todd Cozzens, Jared Kesselheim, MD, and Michael Dixon and not affiliated with SVB or Leerink Capital) shall manage Fund II and whereby Transformation Capital shall manage Fund I’s investment portfolio pursuant to a sub-advisory agreement with SVB (or an affiliate). Transformation Capital has the same operational leader, Kevin Brown, formerly CFO of Leerink Capital, and Transformation Capital expects to continue to derive benefits from its ongoing relationship with Leerink and SVB.
- Total investments:
- 81
- Last investment:
- Lead investor:
- 48%
- Fund size:
- $19M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Transformation Capital invests in
Stages Transformation Capital invests in
Countries Transformation Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 6 contacts → | |||
Round size
- Series B
- $24M–$58M
- Series C
- $23M–$106M
- Series D
- $20M–$163M
Investment Focus
Industry
- Health Care 47 (58%)
- Medical 17 (21%)
- Software 12 (15%)
- Artificial Intelligence 12 (15%)
- Wellness 9 (11%)
Stage
- Series B 20 (25%)
- Series C 17 (21%)
- Series D 9 (11%)
- Series A 8 (10%)
- Funding Round 8 (10%)
Country
- United States 51 (63%)
- New Zealand 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Jared Kesselheim
Co-Founder & Managing Partner
|
Co-Founder & Managing Partner | Total investments: 20 | Find email | |
Jenna Ciotti
Vice President
|
Vice President | Total investments: 1 | Find email | |
Julie Murchinson
Partner
|
Partner | Total investments: 0 | Find email | |
Michael Dixon
Managing Partner
|
Managing Partner | Total investments: 31 | Find email | |
Todd Cozzens
Co-Founder & Managing Partner
|
Co-Founder & Managing Partner | Total investments: 19 | Find email | |
| See all 6 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Abby Care focuses on supporting families by helping caregivers receive compensation through Medicaid for caring for children with disabilities or special needs. The organization aims to place families at the center of its operations, providing resources and guidance to navigate Medicaid processes. Abby Care also offers information on ABA therapyand other supportive services to assist parents and caregivers in enhancing the care they provide. | $82M / Series C / Oct 15, 2026 | ||
| Solstice Health is an AI life sciences marketing platform that offers a clinical data retrieval platform for oncology practice. | $21M / Series A / May 28, 2026 | ||
| Qualified Health is a reliable partner for safely utilizing generative AI in medicine. Qualified Health's infrastructure solution offers safeguards for ongoing algorithm performance monitoring, active AI governance, and developing agents tailored to the healthcare industry. Qualified Health are revolutionizing healthcare in America with tophealth system partners. | $125M / Series B / Mar 25, 2026 | ||
| Latent is a creator of medical language models aimed at reducing healthcare operational costs. | $80M / Series A / Mar 18, 2026 | ||
| We’re on a mission to fundamentally transform mental healthcare accessibility. Grow Therapy empowers therapists to launch and grow thriving in-network private practices. We’re creating game-changing technology to build America’s biggest behavioral healthcare group and ensure that anyone can afford quality mental healthcare. With the mass increasein depression and anxiety from the pandemic, the need for accessibility is more important than ever. To make our vision for mental healthcare a reality, we’re building a team of entrepreneurs and mission-driven go-getters. Our founders come from Harvard Medical School, Stripe, and Blackstone, and are champions of balancing bold ambitions with a culture that promotes holistic well-being. Since launching in 2020, Grow has raised over $15M from top VCs and angel investors, including leaders from SignalFire, Village Global, Airbnb, Nurx, PatientPing, and Blackstone. | $150M / Series D / Mar 03, 2026 | ||
| Alaffia Health offers artificial intelligence solutions that support health plan claims operations by automating and improving clinical review workflows. Its platform uses AI agents to analyze complex medical claims data, extract structured clinical facts, and assist with payment integrity, utilization management, and appeals processing. Thecompany’s tools integrate with existing claims systems to prioritize cases, support clinician review, and help identify errors, waste, and inconsistencies before payment. Alaffia Health combines machine learning with clinician oversight to enhance accuracy in claims decisions and streamline administrative tasks for health insurance payers and related organizations. | $55M / Series B / Feb 03, 2026 | ||
| Tebra provide independent healthcare practices with digital tools and support to thrive in a new era of healthcare.Tebra is to unlock better healthcare for every patient by getting your independent practice the right technology and support to thrive. In an industry marked by broken, disparate parts, and overstuffed with processes, we aredeveloping a single system that can truly be the backbone of practice success. | $250M / Private Equity / Dec 17, 2025 | ||
| Capital Rx is a health technology company that engages in managing pharmacy benefit plans. The company is redefining the way prescriptions are priced and administered in the U.S. Through its Clearinghouse Model, it unlocks the pharmacy supply chain and reduces prescription costs for employer groups. By establishing a competitive marketplace fordrug pricing, Capital Rx focuses its resources on deploying actionable strategies that improve plan performance and patient outcomes. | $252M / Series F / Sep 23, 2025 | ||
| Ketryx provides an AI-powered compliance platform for regulated product development in the life sciences industry. It automates documentation generation, ensures traceability, and enforces quality management procedures. The platform integrates with tools like Jira and GitHub to generate submission-ready documents directly from active developmentworkflows. Ketryx's AI agents detect compliance gaps, suggest actions, and automate routine processes while retaining human oversight. Ketryx helps teams in regulated industries and use their preferred tools. | $39M / Series B / Sep 04, 2025 | ||
| Citizen Health is a personalized AI Advocate platform that helps patients understand and organize their medical information. | $30M / Series A / Aug 14, 2025 | ||
| See all 81 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Transformation Capital invest in?
Transformation Capital invests primarily in Health Care, Medical and Software startups, most often at Series B and Series C stage. Most of the 81 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Transformation Capital invest in?
Transformation Capital typically joins rounds of $24M–$58M at Series B, $23M–$106M at Series C and $20M–$163M at Series D. These are whole funding-round sizes, not Transformation Capital's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Transformation Capital took part in.
How do I contact Transformation Capital?
Public channels for Transformation Capital include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Transformation Capital?
The team at Transformation Capital includes Jared Kesselheim (Co-Founder & Managing Partner), Jenna Ciotti (Vice President) and Julie Murchinson (Partner), among 6 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
